A

Amneal Intermediate Inc
NASDAQ:AMRX

Watchlist Manager
Amneal Intermediate Inc
NASDAQ:AMRX
Watchlist
Price: 8.51 USD -0.7% Market Closed
Market Cap: 2.6B USD
Have any thoughts about
Amneal Intermediate Inc?
Write Note

Amneal Intermediate Inc
Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Amneal Intermediate Inc
Cash Equivalents Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

Company Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
A
Amneal Intermediate Inc
NASDAQ:AMRX
Cash Equivalents
$91.5m
CAGR 3-Years
-36%
CAGR 5-Years
-16%
CAGR 10-Years
-7%
Johnson & Johnson
NYSE:JNJ
Cash Equivalents
$4.8B
CAGR 3-Years
32%
CAGR 5-Years
27%
CAGR 10-Years
-10%
Bristol-Myers Squibb Co
NYSE:BMY
Cash Equivalents
$6.3B
CAGR 3-Years
-17%
CAGR 5-Years
-26%
CAGR 10-Years
4%
Pfizer Inc
NYSE:PFE
Cash Equivalents
$1.1B
CAGR 3-Years
-19%
CAGR 5-Years
-18%
CAGR 10-Years
-8%
Merck & Co Inc
NYSE:MRK
Cash Equivalents
$11.3B
CAGR 3-Years
10%
CAGR 5-Years
11%
CAGR 10-Years
1%
Eli Lilly and Co
NYSE:LLY
Cash Equivalents
$3.2B
CAGR 3-Years
0%
CAGR 5-Years
7%
CAGR 10-Years
-2%

See Also

What is Amneal Intermediate Inc's Cash Equivalents?
Cash Equivalents
91.5m USD

Based on the financial report for Dec 31, 2023, Amneal Intermediate Inc's Cash Equivalents amounts to 91.5m USD.

What is Amneal Intermediate Inc's Cash Equivalents growth rate?
Cash Equivalents CAGR 10Y
-7%

Over the last year, the Cash Equivalents growth was 252%. The average annual Cash Equivalents growth rates for Amneal Intermediate Inc have been -36% over the past three years , -16% over the past five years , and -7% over the past ten years .

Back to Top